Back to search

Article

Maternally administered naltrexone and its major active metabolite 6β-naltrexol transport across the placental barrier <i>in vitro</i>

2020-04-18

Abstract excerpt

Opioid use disorder (OUD) has become a growing concern in the U.S. and has been a dominant presence among pregnant women, resulting in an unprecedented amount of prescription medications, particularly naltrexone (NTX), prescribed for pregnant women. Because of unknown potential harm that NTX can impose on the fetus and its premature brain, the needs for safety and regulation of NTX are still undetermined. To addre...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d1050851-ba69-5262-87ec-2c7e6555c7c2
DOI
10.1101/2020.04.16.045229
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Maternally administered naltrexone and its major active metabolite 6β-naltrexol transport across the placental barrier <i>in vitro</i>DOI 10.1101/2020.04.16.045229
Select a neighboring publication to make it the new centre.